Med Life Future Growth
Future criteria checks 4/6
Med Life is forecast to grow earnings and revenue by 70.4% and 11.2% per annum respectively. EPS is expected to grow by 74.4% per annum. Return on equity is forecast to be 5.7% in 3 years.
Key information
70.4%
Earnings growth rate
74.4%
EPS growth rate
| Healthcare earnings growth | 23.1% |
| Revenue growth rate | 11.2% |
| Future return on equity | 5.7% |
| Analyst coverage | Low |
| Last updated | 04 Apr 2024 |
Recent future growth updates
Recent updates
Is Med Life (BVB:M) A Risky Investment?
Apr 05
Returns On Capital Signal Tricky Times Ahead For Med Life (BVB:M)
Jul 05Is Med Life (BVB:M) A Risky Investment?
Jan 06Med Life (BVB:M) Hasn't Managed To Accelerate Its Returns
Dec 06We Think Med Life (BVB:M) Is Taking Some Risk With Its Debt
Sep 27Returns Are Gaining Momentum At Med Life (BVB:M)
May 05Is There An Opportunity With Med Life S.A.'s (BVB:M) 49% Undervaluation?
Mar 01Med Life (BVB:M) Shareholders Will Want The ROCE Trajectory To Continue
Jan 22Does Med Life (BVB:M) Have A Healthy Balance Sheet?
Aug 31Med Life's (BVB:M) Returns On Capital Are Heading Higher
Jun 10Here's Why We Think Med Life (BVB:M) Is Well Worth Watching
May 26Is Now An Opportune Moment To Examine Med Life S.A. (BVB:M)?
May 12Is There An Opportunity With Med Life S.A.'s (BVB:M) 24% Undervaluation?
Apr 12Update: Med Life (BVB:M) Stock Gained 98% In The Last Year
Mar 16Should We Be Excited About The Trends Of Returns At Med Life (BVB:M)?
Mar 04Should You Be Impressed By Med Life S.A.'s (BVB:M) ROE?
Feb 20
Med Life (BVB:M) Seems To Use Debt Quite Sensibly
Feb 07Is It Too Late To Consider Buying Med Life S.A. (BVB:M)?
Jan 25Do Med Life's (BVB:M) Earnings Warrant Your Attention?
Jan 08Is Med Life S.A. (BVB:M) Trading At A 22% Discount?
Dec 23Did You Miss Med Life's (BVB:M) 49% Share Price Gain?
Dec 08The Trends At Med Life (BVB:M) That You Should Know About
Nov 24Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 2,779 | 30 | 224 | 269 | 2 |
| 12/31/2024 | 2,491 | 23 | 257 | 193 | 2 |
| 12/31/2023 | 2,222 | 4 | -36 | 184 | N/A |
| 9/30/2023 | 2,116 | -11 | 40 | 268 | N/A |
| 6/30/2023 | 2,020 | -3 | -10 | 179 | N/A |
| 3/31/2023 | 1,921 | 12 | 23 | 212 | N/A |
| 12/31/2022 | 1,810 | 32 | 15 | 185 | N/A |
| 9/30/2022 | 1,725 | 64 | 10 | 112 | N/A |
| 6/30/2022 | 1,623 | 80 | 83 | 202 | N/A |
| 3/31/2022 | 1,520 | 98 | 122 | 209 | N/A |
| 1/1/2022 | 1,438 | 103 | 130 | 227 | N/A |
| 9/30/2021 | 1,359 | 107 | 103 | 185 | N/A |
| 6/30/2021 | 1,295 | 112 | 67 | 172 | N/A |
| 3/31/2021 | 1,160 | 83 | 47 | 148 | N/A |
| 1/1/2021 | 1,087 | 57 | 40 | 129 | N/A |
| 9/30/2020 | 1,033 | 36 | 49 | 145 | N/A |
| 6/30/2020 | 974 | 16 | 77 | 134 | N/A |
| 3/31/2020 | 1,007 | 18 | 63 | 113 | N/A |
| 12/31/2019 | 975 | 14 | 54 | 107 | N/A |
| 9/30/2019 | 939 | 20 | 32 | 76 | N/A |
| 6/30/2019 | 902 | 16 | 28 | 71 | N/A |
| 3/31/2019 | 861 | 11 | N/A | N/A | N/A |
| 1/1/2019 | 804 | 13 | -1 | 52 | N/A |
| 9/30/2018 | 745 | 8 | 0 | 47 | N/A |
| 6/30/2018 | 699 | 5 | -12 | 41 | N/A |
| 3/31/2018 | 657 | 5 | N/A | N/A | N/A |
| 1/1/2018 | 628 | 4 | -6 | 36 | N/A |
| 9/30/2017 | 610 | 3 | N/A | 42 | N/A |
| 6/30/2017 | 577 | -2 | N/A | 39 | N/A |
| 3/31/2017 | 539 | -6 | N/A | N/A | N/A |
| 1/1/2017 | 508 | -5 | N/A | 43 | N/A |
| 9/30/2016 | 469 | -1 | N/A | 39 | N/A |
| 12/31/2015 | 396 | 9 | N/A | 42 | N/A |
| 12/31/2014 | 337 | 7 | N/A | 36 | N/A |
| 12/31/2013 | 306 | -4 | N/A | 23 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: M's forecast earnings growth (70.4% per year) is above the savings rate (6.2%).
Earnings vs Market: M's earnings (70.4% per year) are forecast to grow faster than the RO market (1.2% per year).
High Growth Earnings: M's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: M's revenue (11.2% per year) is forecast to grow faster than the RO market (0.3% per year).
High Growth Revenue: M's revenue (11.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: M's Return on Equity is forecast to be low in 3 years time (5.7%).